Quetiapine

Prescription ·Strong evidence ·Reviewed May 2026

Prescription second-generation (atypical) antipsychotic approved for schizophrenia, bipolar disorder (manic and depressive episodes), and as adjunctive therapy for major depressive disorder. Also widely used off-label for insomnia and anxiety at lower doses due to its sedating properties. Carries metabolic risks including weight gain, dyslipidemia, and hyperglycemia. Dosage must be determined by your prescribing physician.

What it's good for
  • Psychotic symptom reduction6
  • Bipolar mood stabilization5,9
  • Adjunctive depression treatment5,9
  • Insomnia improvement (off-label)
  • Manic episode management
What to watch for
  • Sedation and drowsiness
  • Weight gain
  • Dizziness
  • Known hypersensitivity to quetiapine1,2
  • Concurrent use of strong CYP3A4 inhibitors at initiation

The bottom line

Evidence rating strong. Most-documented uses: psychotic symptom reduction, bipolar mood stabilization, adjunctive depression treatment. 12 sources indexed (2013–2023), with 5 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Antagonizes multiple neurotransmitter receptors including dopamine D2, serotonin 5-HT2A, histamine H1 (sedation), and alpha-1 adrenergic receptors (orthostatic hypotension). Lower D2 affinity compared to typical antipsychotics, resulting in lower risk of extrapyramidal symptoms. Active metabolite norquetiapine also inhibits NET reuptake, contributing to antidepressant effects.6

Class
Atypical Antipsychotic
Absorption
Fat-soluble; take with food
Dosing

Dosing & protocol.

Common range
25–800 mg daily depending on indication (as prescribed by your physician)
Recommended form
Tablet or extended-release tablet

Can be taken with or without food. Extended-release formulation should be taken without food or with a light meal (less than 300 calories). Swallow XR tablets whole.

Safety

Full safety detail.

Side effects

  • Sedation and drowsiness
  • Weight gain
  • Dizziness
  • Orthostatic hypotension
  • Dry mouth
  • Dyslipidemia
  • Hyperglycemia
  • Constipation
  • QTc prolongation

Contraindications

  • Known hypersensitivity to quetiapine1,2
  • Concurrent use of strong CYP3A4 inhibitors at initiation
  • Uncontrolled diabetes (relative)
Interactions

Interaction records.

ModerateCaution

Melatonin

Both quetiapine and melatonin have sedative properties, and their combination produces additive CNS depression. Quetiapine is particularly sedating among antipsychotics due to potent histamine H1 receptor antagonism. Adding melatonin may cause excessive drowsiness, impaired cognitive function, and motor coordination problems, especially in elderly patients. However, in some clinical contexts (e.g., managing sundowning in delirium), the combination may be therapeutically beneficial.

Recommendation: If using melatonin with quetiapine, start with the lowest melatonin dose (0.5-1 mg) and take both at bedtime. Avoid driving or operating machinery. Be especially cautious if elderly or taking other CNS depressants. Report excessive daytime drowsiness, confusion, or coordination problems to your prescriber.

DangerousContraindicated

St. John's Wort

St. John's Wort is a potent CYP3A4 inducer that can reduce quetiapine plasma concentrations by up to 80%, essentially rendering the medication ineffective. The FDA-approved labeling for quetiapine states that doses may need to be increased up to 5-fold when co-administered with strong CYP3A4 inducers. Loss of quetiapine efficacy can lead to psychiatric decompensation, psychotic relapse, or manic episodes with potentially dangerous consequences.

Recommendation: Do NOT take St. John's Wort with quetiapine. This combination is contraindicated due to the risk of complete loss of antipsychotic efficacy. If you are currently taking both, contact your prescriber immediately. Do not abruptly stop St. John's Wort as quetiapine levels will rise over 7-14 days.

ModerateCaution

Valerian Root

Valerian root has GABAergic and sedative properties that can produce additive CNS depression when combined with quetiapine. The combination may cause excessive drowsiness, dizziness, confusion, impaired motor coordination, and difficulty concentrating. Elderly patients are at increased risk for falls and respiratory depression. The interaction is pharmacodynamic rather than pharmacokinetic.

Recommendation: Avoid combining valerian root with quetiapine unless approved by your prescriber. If using both, avoid hazardous activities requiring alertness. Start valerian at the lowest dose and monitor for excessive sedation. Elderly patients should be especially cautious. Report excessive drowsiness or confusion to your prescriber.

SeriousConflict

Cannabis (THC-Dominant)

THC-dominant cannabis can conflict with quetiapine's use for psychosis or bipolar mood stabilization. Continued cannabis use after psychosis onset is associated with higher relapse risk and poorer antipsychotic outcomes, and quetiapine's sedating effects can compound cannabis-related impairment. This is especially concerning with high-potency THC, daily use, driving, or other sedatives.

Recommendation: Avoid THC-dominant cannabis while taking quetiapine for psychosis or bipolar disorder. Tell your prescriber if you continue cannabis so they can monitor symptoms, adherence, and oversedation. Do not rely on spacing the doses to make the combination safe.

SeriousCaution

Alcohol

Alcohol can markedly increase quetiapine-related sleepiness, dizziness, slowed reactions, and poor coordination. Quetiapine's antihistamine and alpha-1 blocking effects already make sedation and orthostatic hypotension common, and alcohol can push this into falls, blackouts, or unsafe driving. Risk is highest at night, after dose increases, or with other sedatives.

Recommendation: Avoid alcohol while taking quetiapine. If alcohol was used, do not drive, take extra sleep aids, or take more quetiapine than prescribed. Get urgent help for extreme drowsiness, slow breathing, fainting, or inability to wake.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

6

Reviews & position papers

1
  • 7Quetiapine Fumarate: A Review of Analytical MethodsNeeds reviewPMIDHamsa A, Karumandampalayam Shanmugaramasamy K, Kariyarambath P et al. · Journal of chromatographic science · 2023

    Hamsa A, Karumandampalayam Shanmugaramasamy K, Kariyarambath P et al.. Quetiapine Fumarate: A Review of Analytical Methods. Journal of chromatographic science. 2023

Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Quetiapine in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.